RNA Manufacturing
Guided Tour Series

During a recent webinar by Dr. Venkata Indurthi, Chief Scientific Officer at Aldevron, he discussed mRNA/saRNA Manufacturing: Considerations to Accelerate the Path to Clinic, detailing key upstream and downstream considerations needed for process development in RNA drug substance manufacturing.  

Questions during the Q&A session covered a range of topics, including: 

• Program Development & Support 
• Synthesis Process & Methods 
• Production & Manufacturing 
• Analytics & Testing 
• Therapeutic Delivery & Applications

Because of time limitations, Dr. Indurthi was only able to answer a few of the submitted questions. Therefore, we followed up with an interview with Dr. Indurthi, asking him additional questions for publication in this 5-part guided series focusing on the above topics.  

You can request your copy of this series to learn more about the key considerations in mRNA/saRNA manufacturing for a successful path to the clinic.   

• Request the interview series (return to download page from March-August 2023 for newly released topics)
• View the webinar, mRNA/saRNA Manufacturing: Considerations to Accelerate the Path to Clinic